Toronto, Canada

Jared A Demorat

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Ripple Therapeutics Corporation. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jared A. Demorat

Introduction

Jared A. Demorat is a notable inventor based in Toronto, Canada. He has made significant strides in the field of medical technology, particularly with his innovative patent for an intravitreal injector. His work is aimed at improving the precision and accuracy of eye treatments, which is crucial for patient care.

Latest Patents

Jared holds a patent for an intravitreal injector, which includes needle assemblies designed for the intravitreal injection of an implant into a patient's eye. This invention allows for both unsheathed and sheathed states, ensuring that the needle assemblies are precise and accurate. Such advancements are essential for proper treatment and help prevent further damage to the eye. He has 1 patent to his name.

Career Highlights

Jared is currently associated with Ripple Therapeutics Corporation, where he continues to develop innovative solutions in the medical field. His expertise and dedication to improving patient outcomes through technology are commendable.

Collaborations

Jared has worked alongside talented colleagues, including Dimitra Louka and Ian Charles Parrag. Their collaborative efforts contribute to the advancement of medical technologies and innovations.

Conclusion

Jared A. Demorat's contributions to the field of medical technology, particularly through his intravitreal injector patent, highlight his commitment to enhancing patient care. His work exemplifies the importance of innovation in medicine and its impact on improving treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…